Lantheus Holdings (LNTH) Non-Current Deferred Tax Liability (2014 - 2026)

Lantheus Holdings (LNTH) reported Non-Current Deferred Tax Liability of $53.5 million for Q1 2026, down 1.36% quarter-over-quarter from $54.2 million in Q4 2025.

Lantheus Holdings (LNTH) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $53.5 million in Q1 2026.

  • Non-Current Deferred Tax Liability for Q1 2026 came in at $53.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $53.5 million (changed N/A YoY), and the FY2025 annual result was $54.2 million, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability retreated to $53.5 million in Q1 2026 per LNTH's latest filing, from $54.2 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $55.1 million in Q3 2025 and troughed at $53.5 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 53.51 Mn
Mar 31, 2026 53.51 Mn
Dec 31, 2025 54.25 Mn
Dec 31, 2025 54.25 Mn
Sep 30, 2025 55.08 Mn
Sep 30, 2025 55.08 Mn
Dec 31, 2016 33.20 Mn
Dec 31, 2016 33.20 Mn
Mar 31, 2016 200,000.00
Mar 31, 2016 200,000.00
Dec 31, 2015 32.90 Mn
Dec 31, 2015 32.90 Mn
Dec 31, 2014 247,000.00
Dec 31, 2014 247,000.00